EMEA: Physicians should not prescribe Acomplia (rimonabant)

The European Medicines Agency recommends suspension of the marketing¬†authorisation of Acomplia The European Medicines Agency (EMEA) has recommended the suspension of the marketing authorisation for Acomplia (rimonabant) from Sanofi-Aventis. The EMEA‚Äôs Committee for Medicinal Products for Human Use (CHMP) has concluded that the benefits of Acomplia no longer outweigh its risks and the marketing authorisation […]